Natural Killer Cell (CYNK-001) Infusions in Adults with AML

Clinical trial NCT04310592 · TERMINATED

Trial details

NCT number: NCT04310592
Sponsor: Celularity Incorporated
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Neoplasms by Histologic Type Neoplasms Immunosuppressive Agents Immunologic Factors Physiological Effects of Drugs Alkylating Agents Antimetabolites, Antineoplastic Antiviral Agents Analgesics, Non-narcotic

Start date: 2020-03-12
Primary completion: 2023-01-20
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.